What is the false positive rate of OncuraKit?

The false positive rate is 1 minus specificity. With OncuraKit's two-test confirmatory protocol achieving >99.9% specificity, the false positive rate is less than 0.1% — fewer than 1 in 1,000 healthy people would receive a falsely elevated result. In the published Yenos studies, zero healthy samples exceeded the 1.5× HL threshold on initial testing, suggesting the false positive rate may be even lower in practice. This is considerably better than many traditional cancer screening tests: PSA testing has a false positive rate of approximately 70–80% in men aged 55–69 who undergo biopsy based on elevated PSA, and mammography has an approximately 50% cumulative false-positive rate over 10 years of annual screening.